Welcome to our dedicated page for Weed SEC filings (Ticker: BUDZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The WEED Inc. (BUDZ) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a reporting issuer in the United States. WEED Inc. describes itself as a global cannabis and hemp bioresearch company focused on cannabis-derived compounds for human and animal health, with activities that span landrace genetics, hemp licensing, consumer packaged goods plans and international subsidiaries. Its filings with the U.S. Securities and Exchange Commission give investors and researchers a structured view of how the company reports these activities under federal securities laws.
Among the documents available are periodic reports such as Forms 10-K and 10-Q, along with related notices. For example, WEED Inc. filed a Form 12b-25 (Notification of Late Filing) indicating that its Form 10-Q for the quarter ended September 30, 2025, could not be filed on time without unreasonable effort or expense, and that it expected to file within the extension period allowed by SEC rules. The filing also confirms that all other required periodic reports over the prior 12 months had been submitted and that no significant change in results of operations was anticipated for that quarter.
Because WEED Inc. operates in the cannabis and hemp space, its SEC filings complement the legal and risk disclosures that appear in its news releases, including discussions of U.S. federal cannabis law, money laundering considerations and forward-looking statement cautions. On Stock Titan, users can review these filings alongside AI-powered summaries that highlight key sections, helping to interpret complex language around operations, risk factors and financial reporting.
In addition, the filings page can surface information relevant to topics such as corporate structure, subsidiaries like WEED Australia Ltd. and HEMP BioSciences Inc., and any future registration statements or proxy materials the company may file. By combining real-time EDGAR updates with AI explanations, the BUDZ filings page is designed to make WEED Inc.’s regulatory record easier to navigate for investors, analysts and other interested readers.
WEED, Inc. filed an amended quarterly report for the period ended September 30, 2025, stating the amendment is solely to add iXBRL files and does not change previously reported results. The company generated no revenue for the three and nine months ended September 30, 2025. It reported a net loss of $73,946 for the quarter and $622,018 for the nine-month period, compared with a nine-month net loss of $377,492 a year earlier. Operating expenses for the nine months were $600,805, driven mainly by general and administrative costs of $505,836 and professional fees of $70,413. At September 30, 2025, WEED held $400 in cash, total assets of $532,267, and total liabilities of $1,051,346, resulting in a stockholders’ deficit of $519,079. The company has an accumulated deficit of $85,525,296, continues to rely on related-party loans and stock issued for services, and discloses substantial doubt about its ability to continue as a going concern. As of August 13, 2025, there were 135,932,685 shares of common stock outstanding.
WEED, Inc. reported no revenue for the three and nine months ended September 30, 2025 and continues to operate at a loss. The company recorded a net loss of
Liquidity is very tight: cash fell to
BUDZ filed a notice under Rule 144 for a planned sale of restricted shares. The filing indicates that an affiliate intends to sell 277,683 shares of common stock through broker Wilson Davis, with an aggregate market value of $27,768.00, on or around December 1, 2025 on the OTCQB market. The company reports that there were 123,482,685 shares of common stock outstanding at the time referenced in the notice, which serves as a baseline ownership figure.
The seller originally acquired 2,000,000 common shares from the issuer on October 27, 2016 as part of an employment-related transaction, with the consideration described as services. By signing the notice, the seller represents that they do not know of any material adverse information about BUDZ’s current or prospective operations that has not been publicly disclosed.
WEED, Inc. (BUDZ) filed a Form 12b-25 (NT 10-Q) notifying a late filing of its Quarterly Report on Form 10‑Q for the period ended September 30, 2025.
The company indicated the Form 10‑Q will be filed on or before the fifth calendar day following the prescribed due date, consistent with Rule 12b‑25(b)(2)(ii). WEED, Inc. stated the report could not be filed within the required time without unreasonable effort and expense and noted it is completing its financial statement review.
FAQ
What is the current stock price of Weed (BUDZ)?
What is the market cap of Weed (BUDZ)?
